PHM3 ECONOMIC ANALYSIS OF RECOMBINANT ACTIVATED FACTOR VII IN THE HOME TREATMENT OF MINOR-TO-MODERATE BLEEDS IN HEMOPHILIA PATIENTS WITH INHIBITORS- A U.S. COST-OF-BLEED MODEL
Abstract
Authors
JM Stephens AV Joshi MF Botteman V Munro